Podcast appearances and mentions of Alan S Brown

Content Warning: Tod, Sterbehilfe, Suizid im Kapitel Eremit Marta entsinnt sich, was eigentlich nochmal ein Déjà-vu ist – auf jeden Fall etwas fantastisch-wissenschaftliches. Kuba liest Marijpols Eremit über einen innerlich und äußerlich gespaltenen Mitarbeiter eines besonderen Reisebüros. Und wir besprechen übermenschlich schnelles Cocktailmixen und weitere Favoriten im Speedrunning-Event Awesome Games Done Quick. Kapitelchen & Tracklist 0:00:00 joxer – thieve's tribute CC BY 0:02:35 Déjà Vu 1 0:26:28 Patricia Taxxon – TETCEHCDHODGOG CC BY-SA 0:30:52 Déjà Vu 1 0:54:23 YES NO WAVE MUSIC – Trial CC BY-NC 0:58:11 Eremit 1:10:14 Curt Oren – Of Course CC BY-NC-SA 1:14:16 Sarcopods 1:26:29 YOUTH AGAINST SATAN – HOLLOW DAY CC BY-NC 1:29:44 Audiorätsel 1:42:34 Carsie Blanton – Cool Kids CC BY-NC-SA 1:44:09 AGDQ Highlights 1:52:38 Ausschnitt VA-11 Hall-A: Cyberpunk Bartender Action by a_variety_pack in 31:50 1:58:34 Unsanitary Napkin – Dildo Baggins CC BY-NC-SA Shownotes Déja-Vus: A review of the déjà vu experience von Alan S. Brown (2003) in Psychological bulletin (via semanticscholar.org) Star-Trek-TNG-Folge Déjà Vu (Wikipedia) Marijpols Eremit (marijpol.com) Artikel zu Sarcopod et al. (vox.com) Awesome Games Done Quick: Baldur's Gate 3 in 33 Minuten von maeeeeee Fresh Hops Kaizo SMW - 100% by frozenflygone in 39:21 Grand Theft Auto Vice City Tightened Vice by EnglishBen in 1:36:27 VA-11 Hall-A: Cyberpunk Bartender Action by a_variety_pack in 31:50 (Quelle für den Ausschnitt) Tetris: The Grand Master by JBroms, spc. EricICX and Mackie in 44:00 Crazy Taxi with Live Backing Band by chuckles825 in 18:59 Credits & Lizenz Cover: basierend auf Robert Fludd Metaphysik und Natur- und Kunstgeschichte beider Welten, nämlich des Makro- und des Mikrokosmos, 1617; Public Domain via Wikimedia Commons Diese Folge erscheint unter CC BY-NC-SA 3.0, d.h. unsere Inhalte gerne teilen, remixen, aber uns bitte erwähnen und ja kein Geld verdienen! Musik siehe jeweilige Lizenzen.

ORIGINAL AIR DATE: FEB 6, 2019Many people have experienced déjà vu, the feeling that a situation or event is familiar, though there is no evidence that the situation has been experienced before. Recent studies have shown that roughly two-thirds of people have experienced déjà vu at least once. This episode explores three research articles chronicling the phenomenon and its elements and the range of proposed explanations for it.Research articles:Alan S. Brown, “A Review of the Déjà Vu Experience,” Psychology Bulletin Vol. 129, No. 3 (2003: 394–413Anne. M. Cleary, “Recognition Memory, Familiarity, and Déjà Vu Experiences,” Current Directions in Psychology Science 17:5 (2008): 353-357Alan S. Brown and Elizabeth J. Marsh, “Digging Into Déjà Vu: Recent Research on Possible Mechanisms,” in The Psychology of Learning and Motivation, vol. 53 (ed. Brian Ross; Burlington: Academic Press, 2010), pp.33-62

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Maryam Lustberg, MD, MPH Can cardiac rehabilitation programs play a role in the management of breast cancer survivors? Dr. Maryam Lustberg, Chief of Breast Medical Oncology and the Director of The Breast Cancer Center at Smilow Yale Cancer Center, shares the common risk factors between cardiovascular disease and cancer and why these types of programs are beneficial to patient care.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Sheng Xu, PhD Sheng Xu, Professor of Nanoengineering, Bioengineering, Computer and Electrical Engineering at the UC San Diego Jacobs School of Engineering, meets with Dr. Alan Brown to discuss his innovative technology to change the way we predict cardiovascular risks.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Yvonne Michael, ScD, SM Dr. Yvonne Michael, an Associate Professor at the Dornsife School of Public Health at Drexel University, discusses risk factors that we should take into consideration when examining postmenopausal patients with coronary heart disease.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Dustin Sulak, DO Dr. Dustin Sulak, an integrative medicine physician specializing in osteopathy, mind-body medicine, and medical cannabis, talks about the impact of cannabis on the cardiovascular system.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Heval M. Kelli, MD Guest: Alan Amedi What do we need to know about a career in cardiology? Dr. Alan Brown meets with Dr. Heval Kelli, a cardiologist at the Northside Hospital in Atlanta, and Alan Amedi, a first-year medical school student at Emory University, to explore their experiences in the cardiology field and learn about their perspectives on training.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE How much do we understand the non-traditional risk factors of atherosclerotic cardiovascular disease, or ASCVD, in women? Dr. Erin Michos, an Associate Professor of Medicine and Director of the Women's Cardiovascular Health Center at Johns Hopkins School of Medicine, meets with Dr. Alan Brown to review ASCVD risk factors in women.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Erin D. Michos, MD, MHS, FACC, FAHA, FASE Dr. Erin Michos, the Director of Women’s Cardiovascular Health and the Associate Director of Preventive Cardiology at Johns Hopkins Medicine in Odenton, Maryland briefly discusses clinical practice updates for cardiologists from the 2020 Expert Consensus Decision Pathway.

Host: Alan S. Brown, MD, FNLA Guest: Keith C. Ferdinand, MD Dr. Keith Ferdinand, Tulane University's Gerald S. Berenson Endowed Chair in Preventive Cardiology and Professor of Medicine at the Tulane University School of Medicine, joins Dr. Alan Brown to discuss cardiovascular healthcare disparities among African Americans and what we can do to improve access to care.

Host: Alan S. Brown, MD, FNLA Guest: Keith C. Ferdinand, MD Despite decades of research and advancements in cardiology care, racial disparities remain an obstacle. How can we improve access to care and eliminate this disparity? Dr. Alan Brown is joined by Dr. Keith Ferdinand, professor of medicine at the Tulane University School of Medicine, to discuss what we can do as clinicians to ensure that all of our patients receive the same quality of care.

Host: Alan S. Brown, MD, FNLA Guest: Arun Sharma, PhD Can low gravity and space flight impact our cardiac function? Dr. Arun Sharma, a stem cell biologist at Cedars-Sinai Medical Center in California, joins Dr. Alan Brown to discuss the impact of outer space on the heart.

Host: Alan S. Brown, MD, FNLA Host: Matthew Sorrentino, MD As the field of healthcare continues to change, how will the future of preventative cardiology be impacted? Join our Heart Matters hosts, Dr. Alan Brown and Dr. Mathew Sorrentino, as they sit down to discuss their experiences in preventative cardiology and the future of the healthcare system.

Host: Alan S. Brown, MD, FNLA Host: Matthew Sorrentino, MD Developments in the healthcare community have changed the field of preventative cardiology. But how have they impacted cardiology care? Heart Matters hosts Dr. Alan Brown and Dr. Mathew Sorrentino examine adherence to medicine, improvements to compliance, and new entries into the marketplace surrounding cardiology.

Host: Alan S. Brown, MD, FNLA Guest: Daniel T. Lackland DrPH For decades, news reports have focused on the prevalence of high blood pressure among adults in the U.S. But a recent study claims that blood pressure among these adults has actually decreased between 1960 and 2005. Here to divulge the surprising results of his study and discuss systolic blood pressure improvements in adults in the U.S. is Dr. Daniel Lackland.

Host: Alan S. Brown, MD, FNLA Guest: Jennifer N. Avari Silva, MD While we know that the lungs are deeply affected by COVID-19, they’re far from the only organ to be ravaged by this disease. Dr. Richard Vander Heide, Professor and Director of Pathology Research at LSU Health, New Orleans School of Medicine, joins Dr. Alan Brown to discuss how he led a team of pathologists that performed autopsies on COVID-19 patients to discover the resulting cardiac changes.

Host: Alan S. Brown, MD, FNLA Guest: Jennifer N. Avari Silva, MD While we know that the lungs are deeply affected by COVID-19, they’re far from the only organ to be ravaged by this disease. Dr. Richard Vander Heide, Professor and Director of Pathology Research at LSU Health, New Orleans School of Medicine, joins Dr. Alan Brown to discuss how he led a team of pathologists that performed autopsies on COVID-19 patients to discover the resulting cardiac changes.

This month, host Ann Thomas talks with Alan S. Brown, M.D., M.P.H., about his research on the association of maternal insecticide levels with autism, and on maternal immune activation and neuropsychiatric illness. Executive Editor Michael Roy reviews research on how smoking affects cognitive functioning, a randomized controlled trial of parent-child psychotherapy, and challenges in managing mental health problems in transgender individuals.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Rhoda Cooper-DeHoff. Dr. Cooper-DeHoff is an Associate Professor in the Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine of the Colleges of Pharmacy and Medicine at the University of Florida. She is also Associate Director of the Center for Pharmacogenomics at this institution. Dr. Cooper-DeHoff discusses the rise of pharmacometabolomics, genomic testing, and pharmacogenetic testing in lipidology, with particular emphasis on predictive mapping for statin responses.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Rhoda Cooper-DeHoff. Dr. Cooper-DeHoff is an Associate Professor in the Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine of the Colleges of Pharmacy and Medicine at the University of Florida. She is also Associate Director of the Center for Pharmacogenomics at this institution. Dr. Cooper-DeHoff discusses the rise of pharmacometabolomics, genomic testing, and pharmacogenetic testing in lipidology, with particular emphasis on predictive mapping for statin responses.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dave Dixon, PharmD, Clinical Pharmacist and Associate Professor of Pharmacology at Virginia Commonwealth University School of Pharmacy. Dr. Dixon is also a Board Certified Pharmacotherapy Specialist, Clinical Lipid Specialist, and Fellow of the National Lipid Association. He serves as a Regional Representative for the Southeast Chapter of NLA and on the Journal of Clinical Lipidology Editorial Board. Dr. Dixon discusses guidelines for treating hypertriglyceridemia, effective therapies for reducing triglyceride levels, and emerging lipid-lowering therapies in development.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dave Dixon, PharmD, Clinical Pharmacist and Associate Professor of Pharmacology at Virginia Commonwealth University School of Pharmacy. Dr. Dixon is also a Board Certified Pharmacotherapy Specialist, Clinical Lipid Specialist, and Fellow of the National Lipid Association. He serves as a Regional Representative for the Southeast Chapter of NLA and on the Journal of Clinical Lipidology Editorial Board. Dr. Dixon discusses guidelines for treating hypertriglyceridemia, effective therapies for reducing triglyceride levels, and emerging lipid-lowering therapies in development.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Eugenia Gianos. Dr. Gianos is an assistant professor in the Department of Medicine and co-clinical director of the Center for the Prevention of Cardiovascular Disease at the NYU School of Medicine. Dr. Gianos discusses the effectiveness, potential side effects, and patient outcomes with PCSK9 antibodies for management of dyslipidemia.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Eugenia Gianos. Dr. Gianos is an assistant professor in the Department of Medicine and co-clinical director of the Center for the Prevention of Cardiovascular Disease at the NYU School of Medicine. Dr. Gianos discusses the effectiveness, potential side effects, and patient outcomes with PCSK9 antibodies for management of dyslipidemia.

Host: Alan S. Brown, MD, FNLA Like in the United States, Canadian citizens contend with a high pediatric prevelance of lipid disorders, particularly familial hypercholesterolemia. However, perspectives on clinical care and standards public health priorities to address dyslipidemia differ markedly between these two countries. Can American practitioners and health policy experts alike benefit from Canadian approaches to lipidology? Dr. Alan Brown welcomes Dr. Julie St. Pierre, Professor of Pediatrics at Sherbrooke University in Canada, to discuss pediatric lipid disorder management across North American borders.

Host: Alan S. Brown, MD, FNLA Patients in lipidolgy clinics sometimes undergo diagnostic workups for mild liver enzyme elevations, and in select cases a diagnosis of non-alcoholic fatty liver disease will be made. How does this diagnosis compare with the more inflammatory alcoholic fatty liver disease, and what roles should the lipidologist play in response to these findings? Dr. David Cohen, Professor of Medicine at Harvard Medical School and Director of Hepatology at Brigham and Women's Hospital, joins host Dr. Alan Brown to discuss the pathogenesis and management of non-alcoholic fatty liver disease.

Host: Alan S. Brown, MD, FNLA Like in the United States, Canadian citizens contend with a high pediatric prevelance of lipid disorders, particularly familial hypercholesterolemia. However, perspectives on clinical care and standards public health priorities to address dyslipidemia differ markedly between these two countries. Can American practitioners and health policy experts alike benefit from Canadian approaches to lipidology? Dr. Alan Brown welcomes Dr. Julie St. Pierre, Professor of Pediatrics at Sherbrooke University in Canada, to discuss pediatric lipid disorder management across North American borders.

Host: Alan S. Brown, MD, FNLA Like in the United States, Canadian citizens contend with a high pediatric prevelance of lipid disorders, particularly familial hypercholesterolemia. However, perspectives on clinical care and standards public health priorities to address dyslipidemia differ markedly between these two countries. Can American practitioners and health policy experts alike benefit from Canadian approaches to lipidology? Dr. Alan Brown welcomes Dr. Julie St. Pierre, Professor of Pediatrics at Sherbrooke University in Canada, to discuss pediatric lipid disorder management across North American borders.

Host: Alan S. Brown, MD, FNLA Joining Dr. Alan Brown to discuss the pharmacokinetic data behind drug interactions between treatments for complex lipid abnormalities is Dr. Barbara Wiggins, Pharm.D, clinical pharmacy specialist in cardiology at the Medical University of South Carolina and adjunct professor at the South Carolina School of Pharmacy. Dr. Wiggens has served as a member of the cardiovascular expert panel for the United States Pharmacopoeia.

Host: Alan S. Brown, MD, FNLA Guest: Robert Wild, MD, MPH, D.Phil. Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices. Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University.

Host: Alan S. Brown, MD, FNLA Guest: Robert Wild, MD, MPH, D.Phil. Recorded live at the recent Annual National Lipid Association meeting, Dr. Alan Brown welcomes Dr. Robert Wild to discuss types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception. The two discuss ways for clinicians to trace the source of dyslipidemia in these women, from primary to secondary causes, and how this knowledge can guide future contraception choices. Dr. Robert Wild is Professor of OB/GYN and Adjunct Professor in Biostatistics and Epidemiology at the University of Oklahoma. He is also Adjunct Professor in Epidemiology at the University of Pittsburgh, and Adjunct Professor of Nutrition at Oklahoma State University.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross Host Dr. Alan Brown welcomes Joyce Ross, nurse practitioner and President of the National Lipid Association. Joyce is a consultative education specialist in Cardiovascular Risk Intervention with the University of Pennsylvania Health System. She is the first Nurse Practitioner elected as President of the NLA. Ms. Ross introduces her goals for the upcoming year, including novel efforts on behalf of the NLA to help combat America's obesity epidemic.

Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown welcomes Dr. Seth Martin, cardiologist and assistant professor of medicine at the Johns Hopkins University School of Medicine with a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Martin is a faculty member in the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. Dr. Martin discusses the pursuit of lipid profiles on a national level, utilizing Big Data from health records and clinical trials to develop better understandings of cardiovascular risk and theraputic efficacies.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.

Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Penny Kris-Etherton, Distinguished Professor of Nutrition at Penn State and Past President of NLA. Dr. Kris-Etherton reviews the current dietary recommendations for saturated fat for the population at large and for reducing LDL-C levels. The two discuss the evidence to support these dietary recommendations and optimal replacement nutrients for dietary saturated fatty acids (SFAs).

Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Penny Kris-Etherton, Distinguished Professor of Nutrition at Penn State and Past President of NLA. Dr. Kris-Etherton reviews the current dietary recommendations for saturated fat for the population at large and for reducing LDL-C levels. The two discuss the evidence to support these dietary recommendations and optimal replacement nutrients for dietary saturated fatty acids (SFAs).

Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown welcomes Dr. Steven Nissen, Chairman of the Department of Cardiovascular Medicine and Professor of Medicine at the Lerner School of Medicine of the Cleveland Clinic. The two focus on some of the major developments in lipidology today, from roles of intravascular ultrasound to updates in clinical drug trials to perspectives on past and present guideline recommendations.

Host: Alan S. Brown, MD, FNLA Guest: Harold Bays, MD, FNLA Dr. Alan Brown welcomes Dr. Harold Bays, President of the Southeast Lipid Association and President of the Louisville Metabolic and Atherosclerotic Research Center in Louisville, KY. Dr. Bays led a novel educational effort to provide an annual summary of clinical lipidology to readers of the Journal of Clinical Lipidology. With insightful commentaries of value to lipidologists and generalists alike, the annual summary is expected to pave new ground in the ongoing effort to keep clinicians up to date with the field.

Host: Alan S. Brown, MD, FNLA Guest: Allan Sniderman, MD Risk is calculated by a variety of algorithms, all of which produce an estimate for that individual based on age, gender, cholesterol, blood pressure, and smoking history. The estimate is critical to clinical decision-making, but how accurate is it? Host Dr. Alan Brown welcomes Dr. Allan Sniderman, Edwards Professor of Cardiology at McGill University, to discuss why we should pay more attention to the causes, and less to the risks, of cardiovascular disease. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Medication Adherence: is it the Achilles Heel in your therapies for patients with dyslipidemia? Dr. Lynne Braun, nurse practitioner in the Preventive Cardiology Center and the Heart Center for Women, and Professor in the Department of Adult Health Nursing at the Rush College of Nursing in Chicago, targets three critical barriers to lipid medication adherance: weak patient-provider relationships, health illiteracy, and poor health care transitions after hospital discharge. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Dr. Alan Brown welcomes Dr. Peter Jones, Associate Professor of Medicine and Atherosclorosis/Lipidology at Baylor College of Medicine in Houston, TX. They review special populations in the treatment of dyslipidemia, including Asians, women, elderly patients, and the immune-compromised. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Guest: Keith Ferdinand, MD Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA One of the most recurrent questions that cardiologists and lipidologists face in daily practice is how to best approach the elderly patient with dyslipidemia. Joining Dr. Alan Brown for special considerations in this population and guideline-based recommendations for management is Joyce Ross, certified registered nurse practitioner, clinical lipid specialist, and President-Elect of the National Lipid Association. Supported by an Educational Grant from AstraZeneca.

Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown welcomes Dr. Don Wilson, Endocrinologist at Cook Children's Health Care System, Fort Worth, Texas. Dr. Wilson will review dyslipidemia in children and adolescent patients. Key points of their discussion will cover the association between abnormal lipid levels in children and an increased lifetime risk of atherosclerotic CVD, as well as, the CVD risk factors present in children and how it tracks from childhood to adulthood. Supported by an Educational Grant from AstraZeneca. Supported by an Educational Grant from AstraZeneca. - See more at: https://reachmd.com/programs/lipid-luminations/million-hearts-initiative-dr-janet-wright-executive-director/7439/#sthash.aVHL9OOn.dpuf Supported by an Educational Grant from AstraZeneca. - See more at: https://reachmd.com/programs/lipid-luminations/million-hearts-initiative-dr-janet-wright-executive-director/7439/#sthash.aVHL9OOn.dpuf

Host: Alan S. Brown, MD, FNLA In this session of Lipid Luminations, host Dr. Alan Brown welcomes Dr. Merle Myerson, founder and director of the Cardiovascular Disease Prevention Program, Lipid Clinic, Pre-Exercise Heart Screening Program, and Cardiology Section/Institute for Advanced Medicine (HIV) at Mount Sinai St. Luke's and Mount Sinai Roosevelt Hospitals. Dr. Myerson reviews the guidelines for prevention, diagnosis, and management of dyslipidemia in patients with HIV.